コンテンツへスキップ
Merck

SAB4200352

Sigma-Aldrich

Anti-DLC1 (C-terminal) antibody produced in rabbit

enhanced validation

~1.5 mg/mL, affinity isolated antibody

別名:

抗ARHGAP7抗体, 抗FLJ21120抗体, 抗HP抗体, 抗STARD12抗体, 抗p122-RhoGAP抗体

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352203
NACRES:
NA.41

由来生物

rabbit

結合体

unconjugated

抗体製品の状態

affinity isolated antibody

抗体製品タイプ

primary antibodies

クローン

polyclonal

フォーム

buffered aqueous solution

分子量

antigen ~200 kDa

交差性

human

強化検証

recombinant expression
Learn more about Antibody Enhanced Validation

濃度

~1.5 mg/mL

テクニック

western blot: 1-2 μg/mL using lysates of HEK-293T cells overexpressing human DLC1.

UniProtアクセッション番号

輸送温度

dry ice

保管温度

−20°C

ターゲットの翻訳後修飾

unmodified

遺伝子情報

human ... DLC1(10395)

詳細

Deleted in liver cancer 1 (DLC1) is a candidate tumor suppressor gene, originally obtained from human hepatocellular carcinoma (HCC). It is mapped to the human chromosome location 8p21-22. The DLC1 gene is majorly expressed in normal human tissues. It contains three major functional domains, sterile α-motif (SAM), Rho guanosine triphosphatase-activating protein (RhoGAP), and steroidogenic acute regulatory-related lipid transfer (START) domains. The N-terminal region of DLC1 localizes to focal adhesions by binding to Src Homology 2 (SH2) domains on tensins.

特異性

Anti-DLC1(C-terminal) specifically recognizes human DLC1.

免疫原

synthetic peptide corresponding to a sequence at the C-terminal of human DLC1, conjugated to KLH. The antibody is affinity-purified using the immunizing peptide immobilized on agarose.

アプリケーション

Anti-DLC1 (C-terminal) antibody produced in rabbit may be used in immunoblotting.

生物化学的/生理学的作用

Deleted in liver cancer 1 (DLC1) interacts with tensin2, a focal adhesion protein, localized at the end of stress fibers, which plays key roles in cytoskeletal organization and cell signaling. Mutations in the focal adhesion targeting (FAT) region of DLC1 reduces its expression and function. The focal adhesion localization of DLC1 is critical for cell motility and morphology. It is also critical for the tumor suppressor activity of DLC1 and under expressed in human hepatocellular carcinoma (HCC) and a variety of cancer types.

物理的形状

Solution in 0.01 M phos­phate buffered saline, pH 7.4, containing 15 mM sodium azide.

保管および安定性

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

免責事項

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

適切な製品が見つかりませんか。  

製品選択ツール.をお試しください

保管分類コード

10 - Combustible liquids

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

IXO14141:
SAB4200352-BULK:
SAB4200352-200UL:
SAB4200352-VAR:


最新バージョンのいずれかを選択してください:

試験成績書(COA)

Lot/Batch Number

適切なバージョンが見つかりませんか。

特定のバージョンが必要な場合は、ロット番号またはバッチ番号で特定の証明書を検索できます。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology
Kawai K, et al.
Genes Cells, 14(2), 227-241 (2009)
Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections
Wolosz D, et al.
Oncology Letters, 8(2), 785-788 (2014)
Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function
Liao YC, et al.
Cancer Research, 68(19), 7718-7722 (2008)
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics
Zimonjic DB and Popescu NC
International Journal of Oncology, 41(2), 393-406 (2012)
Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver
Liao YC and Lo SH
The International Journal of Biochemistry & Cell Biology, 40(5), 843-847 (2008)

質問

レビュー

評価値なし

アクティブなフィルタ

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)